ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

November 10, 2009 15:46 ET

ProMetic Announces Details of the Conference Call / Webcast for its Third Quarter 2009 Financial Results

MONTREAL, QUEBEC, CANADA--(Marketwire - Nov. 10, 2009) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announces that the Company will be holding a conference call / webcast on Monday, November 16, 2009, at 10:30 (EST) further to the release of its third quarter 2009 financial results after the close of market on Friday, November 13, 2009.

The numbers to access the conference call are (416) 620-2407 (international) and 1 (800) 215-2393 (toll free). A live audio webcast of the conference call will be available through ProMetic's website at

A replay of the call will be available by telephone for a period of seven days as of Monday, November 16, 2009, at 12:00 (EST). The numbers to access the audio replay are (416) 626-4100 (international) and 1 (800) 558-5253 (toll free) using access code 21442463. The replay of the web cast may be downloaded directly from ProMetic's web site.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") ( is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the UK, the US and Canada, manufacturing facilities in the UK and business development activities in the US, Europe, Asia and in the Middle-East.

Contact Information